MacroGenics Files DEF 14A: Executive Compensation Details
Ticker: MGNX · Form: DEF 14A · Filed: Apr 11, 2025 · CIK: 1125345
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: MGNX
TL;DR
MGNX proxy statement out, detailing exec pay and equity awards for 2024.
AI Summary
MacroGenics Inc. filed a DEF 14A on April 11, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to both principal executive officers (PEO) and non-PEO/NEO members for the years 2022, 2023, and 2024, with specific details on outstanding and unvested awards as of year-end.
Why It Matters
This filing provides transparency into how MacroGenics compensates its top executives, which can influence investor perception and the company's ability to attract and retain talent.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information on executive compensation and corporate governance, with no immediate material financial events indicated.
Key Numbers
- 2024 — Fiscal Year End (Data presented in the filing pertains to this fiscal year and prior years.)
- 2023 — Fiscal Year End (Data presented in the filing pertains to this fiscal year and prior years.)
- 2022 — Fiscal Year End (Data presented in the filing pertains to this fiscal year and prior years.)
Key Players & Entities
- MacroGenics Inc. (company) — Filer of the DEF 14A
- 20250411 (date) — Filing date of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for compensation data
- 2023-12-31 (date) — Previous fiscal year end for compensation data
- 2022-12-31 (date) — Prior fiscal year end for compensation data
FAQ
What is the filing date of this DEF 14A for MacroGenics Inc.?
The DEF 14A filing for MacroGenics Inc. was filed on 20250411.
What fiscal year does the compensation data primarily cover?
The compensation data primarily covers the fiscal year ending 2024-12-31, with comparative data for 2023 and 2022.
What type of information is detailed in this DEF 14A filing?
This DEF 14A filing details executive compensation, including equity awards granted to PEO and non-PEO/NEO members, and outstanding/unvested awards.
What is the Standard Industrial Classification (SIC) code for MacroGenics Inc.?
The SIC code for MacroGenics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of MacroGenics Inc.?
The business address of MacroGenics Inc. is 9704 Medical Center Drive, Rockville, MD 20850.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 11, 2025 regarding MACROGENICS INC (MGNX).